NOTIFICATION OF THE REMOVAL FROM LISTING
AND REGISTRATION OF THE STATED SECURITIES

The null hereby notifies the SEC of its
intention to remove the entire class
 of the stated securities from
listing and registration on the Exchange at the
opening of business on February 22, 2013, pursuant
o the provisions of Rule 12d2-2 (a).

[ X ] 17 CFR 240.12d2-2(a)(3) That on
February 8, 2013 the instruments
representing the securities comprising
the entire class of this security came
to evidence, by operation of law or
otherwise, other securities in
substitution therefore and represent
no other right except, if such be the fact,
the right to receive an immediate cash payment.

The merger between YM BioSciences Inc.
and 3268218 Nova Scotia Limited,
a wholly-owned subsidiary of
Gilead Sciences, Inc. became effective on
February 8, 2013. Each share of Common Stock
of YM BioSciences Inc. was
converted into $2.95 in cash per share.

The Exchange also notifies the Securities and
Exchange Commission that as a result of the above
indicated conditions this security was suspended from
trading on February 11, 2013.